Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
浙江医药药品申报生产获得受理
Read online
浙江医药药品申报生产获得受理
5月31日,浙江医药股份有限公司(浙江医药)发布公告称,公司与太景医药研发(北京)有限公司共同申报注册的苹果酸奈诺沙星氯化钠注射液获得浙江省食品药品监督管理局受理通知书。但在申报生产受理后,尚需通过国家食品药品监督管理局相关审评程序批准后方可投入生产。 浙江医药表示,苹果酸奈诺沙星可作为社区获得性肺炎一线用药,且该药品为创新药,除胶囊剂在中国境内和台湾地区上市外,未在其他国家和地区上市,具有广阔的市场前景。同类药品喹诺酮类药物2016年全球销售额19.43亿美元,国内市场重要城市医院用药销售额1...
Vitamins China E-News 201706 (Chinese version)
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...